BioMarin Pharmaceutical Inc.
Gregory R Friberg (EVP, Chief R&D Officer) reports BMRN insider transactions
About this filing
BioMarin Pharmaceutical Inc. (BMRN) filed Form 4 (insider transaction) with the SEC on Oct 1, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Gregory R Friberg · EVP, Chief R&D Officer
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | F · tax withholding | −4,086 | $60.00 | $245,160.00 | 47,732 | Direct |
More BMRN filings
- SC 13G
Filed Nov 20, 2026
- 4
Filed Nov 19, 2026
- 144
Filed Nov 18, 2026
- 10-Q
Filed Nov 3, 2026
- 8-K
Filed Nov 2, 2026
- 8-K
Filed Oct 6, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.